Suppr超能文献

通过体内荧光光度法以及对正常和糖尿病大鼠进行玻璃体提取来测定玻璃体荧光素蓄积情况。

Vitreous fluorescein accumulation determined by in vivo fluorophotometry and by vitreous extraction in normal and diabetic rats.

作者信息

Kaufmann F, Lacoste C

出版信息

Diabetologia. 1986 Mar;29(3):175-80. doi: 10.1007/BF02427089.

Abstract

Vitreous fluorophotometry was performed on pigmented male rats (Piebald strain) 2 weeks after induction of diabetes by streptozotocin. In vivo fluorophotometry data were compared with measurements obtained by direct extraction of the vitreous 60 min after an intravenous injection of sodium fluorescein. In addition, the rate of fluorescein disappearance from blood plasma, plasma protein binding of fluorescein and the effect of insulin treatment of diabetic animals were investigated. Age-matched nondiabetic animals served as controls. In vivo fluorophotometric measurements showed a good correlation with fluorescein determinations after direct extraction of the vitreous. Vitreous fluorescein concentrations were similar in diabetic and normal rats and were strongly related to the dye plasma levels within each group of animals. In the diabetic rats, however, the elimination of plasma fluorescein was accelerated and the percentage of free fluorescein, as determined by ultrafiltration and equilibrium dialysis, was consistently higher (130-150% of controls). The ratios of vitreous to total or free plasma fluorescein levels were elevated in diabetic rats. Experimental data indicate that plasma concentration of free fluorescein is crucial for vitreous dye accumulation. Insulin treatment of diabetic rats markedly improved their metabolic state and normalized the plasma fluorescein elimination and the vitreous to plasma fluorescein concentration ratios. It is concluded that vitreous fluorophotometry can be adequately applied to pigmented rats, provided that plasma fluorescein elimination rate and protein binding are considered in the interpretation of the results, since both influence the vitreous fluorescein accumulation and both may be altered by disease and drug treatment.

摘要

对用链脲佐菌素诱导糖尿病2周后的雄性有色大鼠(花斑品系)进行玻璃体液荧光光度测定。将体内荧光光度测定数据与静脉注射荧光素钠60分钟后直接抽取玻璃体液所获得的测量值进行比较。此外,还研究了荧光素从血浆中消失的速率、荧光素与血浆蛋白的结合以及胰岛素治疗对糖尿病动物的影响。年龄匹配的非糖尿病动物作为对照。体内荧光光度测量结果与直接抽取玻璃体液后的荧光素测定结果具有良好的相关性。糖尿病大鼠和正常大鼠的玻璃体液荧光素浓度相似,并且与每组动物体内的染料血浆水平密切相关。然而,在糖尿病大鼠中,血浆荧光素的消除加速,通过超滤和平衡透析测定的游离荧光素百分比始终较高(为对照组的130 - 150%)。糖尿病大鼠玻璃体液与总血浆或游离血浆荧光素水平的比率升高。实验数据表明,游离荧光素的血浆浓度对于玻璃体液中染料的积累至关重要。对糖尿病大鼠进行胰岛素治疗可显著改善其代谢状态,并使血浆荧光素消除以及玻璃体液与血浆荧光素浓度比率恢复正常。结论是,只要在解释结果时考虑血浆荧光素消除速率和蛋白结合情况,玻璃体液荧光光度测定就可以适用于有色大鼠,因为这两者都会影响玻璃体液荧光素的积累,并且都可能因疾病和药物治疗而改变。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验